Aptahem
0.70 SEK
+2.94 %
Less than 1K followers
APTA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+2.94 %
+1.49 %
-21.68 %
-37.07 %
-35.37 %
-50.02 %
-97.37 %
-99.29 %
-99.86 %
Aptahem operates in the pharmaceutical industry. The company develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's lead candidate is being developed as an emergency drug intended to prevent the onset of life-threatening organ and tissue damage in patients suffering from sepsis. A large part of the research is carried out in collaboration with partners in the industry. The company was founded in 2014 and is headquartered in Malmö.
Read moreMarket cap
18.15M SEK
Turnover
13.12K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.5
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
Aptahem receives patent protection in China for patent family 2
Aptahem's webinar "Strategic Direction and Planned US Listing" now available
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools